To further investigate the combined contribution of YAP/TEAD and gp130/STAT3 pathway activation in a clinical context, we evaluated publicly available, The Cancer Genome Atlas stomach adenocarcinoma datasets (TCGA-STAD) to establish expression patterns. Here, YAP1 is linked to gastric adenocarcinoma.